BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28376082)

  • 1. Serum inflammatory markers and colorectal cancer risk and survival.
    Ghuman S; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
    Br J Cancer; 2017 May; 116(10):1358-1365. PubMed ID: 28376082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
    Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
    BMC Cancer; 2019 Aug; 19(1):858. PubMed ID: 31464604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
    Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
    Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
    Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
    Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
    Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of outcome after curative surgery for colorectal cancer: preoperative haemoglobin, C-reactive protein and albumin.
    Egenvall M; Mörner M; Martling A; Gunnarsson U
    Colorectal Dis; 2018 Jan; 20(1):26-34. PubMed ID: 28685921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study.
    Arthur R; Møller H; Garmo H; Häggström C; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
    Cancer Causes Control; 2019 Feb; 30(2):195-206. PubMed ID: 30421156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
    Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
    Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase proteins and incidence of diabetes: a population-based cohort study.
    Muhammad IF; Borné Y; Hedblad B; Nilsson PM; Persson M; Engström G
    Acta Diabetol; 2016 Dec; 53(6):981-989. PubMed ID: 27581604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
    Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
    Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
    Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
    Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
    Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
    Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
    Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Watt DG; McSorley ST; Park JH; Horgan PG; McMillan DC
    Ann Surg Oncol; 2017 Apr; 24(4):1100-1109. PubMed ID: 27822634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study.
    Santaolalla A; Sollie S; Rislan A; Josephs DH; Hammar N; Walldius G; Garmo H; Karagiannis SN; Van Hemelrijck M
    BMC Immunol; 2021 Sep; 22(1):61. PubMed ID: 34488637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.